findmyKOL
Clinical trialNCT02656342CompletedPhase 4Interventional

Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients?

SponsorHaukeland University HospitalEnrollment163Obsessive-Compulsive Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Norway
  • Haukeland University Hospital

    Bergen, Norway

  • Innlandet Hospital

    Brumunddal, Norway

  • Forde Hospital

    Førde, Norway

  • Sørlandet Hospital

    Kristiansand, Norway

  • Nord Trøndelag Hospital

    Levanger, Norway

  • Akershus University Hospital

    Lorenskog, Norway

  • More and Romsdal Hospital

    Molde, Norway

  • Østfold Hospital

    Moss, Norway

  • Oslo University Hospital

    Oslo, Norway

  • Vestre Viken

    Sandvika, Norway

  • Stavanger University Hospital

    Stavanger, Norway

  • Tromso University Hospital

    Tromsø, Norway

  • St. Olavs Hospital

    Trondheim, Norway

  • Sykehuset I Vestfold

    Tønsberg, Norway

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2015
Primary completion
30 Sept 2018
Completion
28 Feb 2019
Last update posted
11 Feb 2021
Registered enrollment
163
Registry id
NCT02656342

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-002574-49

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.